by Kevin Bambury | Feb 2, 2017 | News
Killarney, February 7th 2017: Irish Medical Device Company, Portable Medical Technology, has finalized a partnership with the European Oncology Nursing Society to make it’s flagship product, ONCOassist available to over 20,000 oncology nurses throughout Europe.
ONCOassist is a CE approved decision support application for oncology professionals. It offers oncology nurses and doctors easy access to the decision support tools and information they need via smartphone and tablet application. It is one of the first apps on the market to come with the required regulatory approval enabling it to be used in a hospital setting.
ONCOassist Co-founder Kevin Bambury commenting on the agreement said “ONCOassist’s suite of CE approved decision support tools is used on a daily basis by medical oncologists globally, and through this new agreement with the European Oncology Nursing Society we will expand our reach beyond medical oncologists to oncology nurses. These are very exciting times for ONCOassist.”
Erik Van Muilekom Past President of the European Oncology Nursing Society commented, “ONCOassist is a very useful tool for oncology nurses to use on a daily basis. ONCOassist offers tools like steroid and opiate equivalency converters which are extremely useful, and are now available in a safe, validated format on your smartphone or tablet.”
“There is currently no CE approved app like ONCOassist available for oncology professionals on the market. Decisions are made daily in hospitals around the world using apps that do not have the required regulatory approval. We are delighted to add the 20,000 EONS members to our growing fast growing user base.” said Co-Founder and CEO Eoin O’Carroll.
Welcoming the announcement MEP Sean Kelly stated, “This is an important development for innovative small business in Ireland, given the potential significance of this novel technology, the results of which include saving lives. I look forward to following the results of this innovative technology in the future. It is further evidence of the importance of innovative local companies to the long-term development of the regional economy and I’m delighted to see a partnership with a European Association. This cooperation is the very essence of what EU means and shows the benefit of being a Member of the EU. ”
ONCOassist is based in Killarney, Co. Kerry, it was founded by Kevin Bambury, Eoin O’Carroll and Dr. Richard Bambury who are all graduates of University College Cork. It has been funded by Enterprise Ireland and Chicago based VC Healthbox. It counts 9 out of the top 10 pharmaceutical companies in the world amongst its customers and plans to grow its staff in early 2017.
* * * ENDS * * *
For more information, contact
Kevin Bambury – Portable Medical Technology
+ 353 21 731 9541
kevin@portablemedicaltechnology.com
About ONCOassist
ONCOassist is a clinical decision support app for oncology professionals. It contains all the clinical tools oncology professionals need in an easy to use and interactive format. It is offered as a member benefit by the European Society of Medical Oncology and has rapidly growing global userbase. ONCOassist was found in 2012 by Kevin Bambury, Eoin O’Carroll and Dr Richard Bambury.
About European Oncology Nursing Society
The European Oncology Nursing Society is a pan-European organisation dedicated to the support and development of cancer nurses.
Through our individual members and national societies we engage in projects to help nurses develop their skills, network with each other and raise the profile of cancer nursing across Europe. EONS is an independent, not-for-profit, voluntary organisation.
by Eoin O'Carroll | May 6, 2014 | News
Hospitals and staff operate in a controlled environment where guidelines and protocols are in place. These guidelines and protocols are essential to every hospital as they provide frameworks for working with multi-discipline teams and allow NHS staff to put a standardisation of care into practice. This has a major effect in patient care as it reduces the variation in treatment and thus reduces the chances of error.
Hospitals guidelines and protocols in the UK are all quite similar. They derive from the National Institute For Clinical Excellence (“Nice”). For every hospital, there are variations depending on treatments or staffing availability. As a result every hospital has a vast array of guidelines and protocols, these can reach into thousands of pages.
There are two common ways that all hospitals can access these documents at the moment.
1. Through hard copy books that are distributed to individual staff members.
2. Through the hospital intranet.
Hard copy books are the more traditional means. They cause headaches for both medical staff and the protocol development team maintaining the documents. The obvious headache for hospital staff is the need to carry documents from ward to ward. For the protocol development team there is an issue of document control. With every new edition released, the protocol development team must make sure the out of date document is returned. This can be a logistical nightmare and in some cases there is a concern that out of date documentation is still in use.
The hospital intranet is a more robust system for alleviating problems of document control. But it has its own problems. One of access, even though some medical staff would have their own dedicated PC or laptop the large majority of staff rely on shared computer access. To make things worse, users need to login to the hospital system every time they access shared computers. Searching for the required information can be an issue as the intranet only makes the documentation available through PDF files.
At present the workload and strain on hospital staff is increasing. In order to utilise their time staff may consider not referencing guidelines and protocols. Instead they may rely on past knowledge which could increase the risk of medical error. There is a concern that changes in drug dosages or acute emergency guidance may be overlooked.
It becomes even more of an issue for trainee medical staff who in a lot of cases are placed on 6 month rotations in hospitals. Guidance for these individuals is important. Especially with the short period of time/ learning curve that they need to get up to speed with new hospital environment. The problem outlined for experienced staff are the same for these trainees. But is magnified with the pressure and time limitations they have at a Trust.
Initiatives like having the NHS paperless by 2018 and the Nursing Technology Fund mean that mobile devices are becoming the norm in hospitals throughout the UK. This has opened up opportunities to change the shape of how hospitals distribute and maintain their guidelines and protocols. Our Enterprise Solution ONCOassist has done just that. The application allows Oncology departments to integrate these documents in an interactive manner..
Our unique interactive format allows users to navigate with ease and speed. There is no need to trawl through PDF’s and paper documents.
Protocol development teams no longer need to worry about document control among staff. Portable Medical Technology use a cloud based system that syncs with mobile devices. It will keep all software and documentation up to date with the latest changes.
ONCOassist’s Enterprise Solution is also Bring Your Own Device (BYOD) friendly. This allows all staff access to critical information. Thus the need to distribute hospital devices to all staff is not needed.
Medical Students no longer need to worry about the vast array of information. The information they need will be in the palm of their hand. The interactive manner allows them to access the most critical information they need. No longer will they have to leave a patient’s bedside to find, to wait, to access, and then go through pdf’s on a computer to find what they need.
ONCOassist provides users with interactive formulas and prognostic tools that are CE approved. Hospitals will be able to notify staff of changes through push notifications and news feeds. Tracking of usage will give hospitals clear indications of adherence.
The benefits are clear. Reduced time, reduced chances of error and increased quality of care.
If you want further details on ONCOassist’s Enterprise Solution please contact us at info@oncoassist.com
by Kevin Bambury | Apr 17, 2014 | News
Healthcare IT has long been dominated by large institutional players; these larger vendors had the capacity to withstand the long sales cycles and large up front development costs. However, they have not had the same incentives to integrate and partner as smaller companies. Much to frustration of healthcare providers, this has resulted in fragmented systems that are not interconnected.
Thankfully, things are about to change, a new slew of digital health start ups supported by health accelerators like Healthbox, Startup Health and Rockhealth have begun to gain market traction. You learn quickly as a start-up that you need to “collaborate or die.” . You can’t do everything, so work with the right people to create meaningful solutions to real problems. This is particularly relevant in the case of electronic health records communicating and interacting with decision support systems like ONCOassist.
Wouldn’t it be great if all of the ONCOassist’s calculations and prognostic algorithms were auto-populated providing instantaneous decision support information? A recent study by the West Institute estimated that software interoperability could save $30 billion annually.
In the long run interoperability seems like it makes sense to everyone; look at the success of the Apple and Android App Stores. This is an example of large company opening its doors to developers and entrepreneurs who create win-win situations. Customers get great niche products that add value to their existing platforms and both the developer and the hardware vendor share in the profits.
We haven’t seen this kind of success yet in digital health. Some of the newer electronic health records are beginning to open their platforms and invite integration. Examples of this include Medopad, Evolve and Dr. Chrono(who recently opened their API). Before the dream of interoperability can be realized there are numerous obstacles that need to be overcome, these include :
Regulatory
Apps vary in the dangers they pose to patients. The FDA and the EU stratify these into classification systems. The more danger your app poses the greater the overhead. This is a new space and regulatory agencies are just starting to get to grip with how to manage healthcare apps. Integration between apps and EHR is a whole other quagmire that needs to be managed. The FDA has recently announced that they will be issuing draft guidance on interoperability in the coming months.
Technical
Unlike the development of apps where you have 3 main players, Android, Windows and Apple, the electronic health record market is massively varied. There are numerous EHR vendors; some are built using old technologies which makes them more difficult to access. This provides a huge challenge for even the most well resourced development teams.
Commercial
Like everything in Healthcare a good business case is required before a customer will sign off on paying for the integration of an app with an existing system. Whereas the efficiency gains may seem obvious to us, they may not to be so obvious to the CFO of a large healthcare institution. Also, agreements must be made between the electronic health record provider and the app developer. Both parties must be incentivised correctly.
Although a hospital where all software systems speak to each other is inevitable, as a developer of a fully compliant medical app we see a number of challenges that must be overcome, collaboration between entrepreneurs, providers and vendors (both big and small) over the coming years is critical in overcoming these obstacles and giving the providers access to the systems they deserve.
Are you a healthcare provider,EHR or entrepreneur? Want to work together? Contact us, we want to hear from you.
His insights underscore the urgent need for global oncology equity, especially in low‑resource settings where systemic gaps and lack of auditing hinder outcomes. Explore more stories & insights on ONCOassist. Your clinical edge, just a tap away. 
By integrating five major prognostic models IPSS, DIPSS, DIPSS-Plus, MIPSS70, and MIPSS70-Plus, into a single, intuitive interface, the tool allows oncologists to input 12 variables and receive comprehensive risk stratification in under 90 seconds. From simplifying transplant discussions to supporting more confident, informed treatment planning, this tool is a game-changer in managing myelofibrosis.
, an open‑letter moment, AI in decision‑making, and the fight back against pseudoscience and viral influencers. His story is a powerful call for physicians to reclaim the social‑media narrative.